Recent Articles

What could be causing your blurry vision?

Avocado nutrition: Health benefits and easy recipes

Swimming lessons save lives: What parents should know

Preventing and treating iliotibial (IT) band syndrome: Tips for pain-free movement

Wildfires: How to cope when smoke affects air quality and health

What can magnesium do for you and how much do you need?

Dry socket: Preventing and treating a painful condition that can occur after tooth extraction

What happens during sleep — and how to improve it

How is metastatic prostate cancer detected and treated in men over 70?

Could biofeedback help your migraines?

For "bad" cholesterol, lower is better; dual drug therapy may help

High cholesterol, in particular high low-density lipoprotein (LDL), the so-called bad cholesterol, is a key cause of heart disease. A large clinical trial called IMPROVE-IT set out in 2005 to answer two key questions about LDL:

How low should drug therapy drive LDL?
Can drugs other than statins, the gold standard for lowering cholesterol, help?

The results of IMPROVE-IT were recently published in The New England Journal of Medicine.

Dr. Deepak L. Bhatt, Editor in Chief of the Harvard Heart Letter, talked about the significance of the IMPROVE-IT findings with Dr. Christopher P. Cannon, the trial's lead investigator, and Dr. John A. Jarcho, an editor of The New England Journal of Medicine.

Print This Page

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.